Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- ...
Please provide your email address to receive an email when new articles are posted on . A Houston-area neurohealth company announced completion of a full production test run, along with usability, ...
Please provide your email address to receive an email when new articles are posted on . Results from a clinical trial examining intracranial stimulation using a novel device in those with mild ...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has ...
A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for treating attention-deficit/hyperactivity disorder, does not effectively ...
In the study, "A wearable repetitive transcranial magnetic stimulation device," published in Nature Communications, researchers developed and tested a portable brain stimulation system by combining ...
We may receive a portion of sales if you purchase a product through a link in this article. If you’ve ever undergone physical therapy, your therapist may have used electrical stimulation, or e-stim, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results